Smart Inhalers Market by Product (Inhalers and Nebulizers), Indication (Asthma and COPD), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2019 - 2026
The global smart inhalers market size was valued at $34 million in 2018 and is estimated to reach $1,406 million by 2026, growing at a CAGR of 58.4% from 2019 to 2026. Smart inhalers are clip-on sensors, also known as connected inhalers, which are attached to the traditional inhalers. They are used to track the medication, dosage, and time taken for each dose linked wirelessly to the cloud. These inhalers are part of “Internet of Things,” thus providing correct use of the medication, improved adherence to the inhaler, and better health outcomes. Doctors and patients can easily benefit from the use of smart inhalers as they monitor the dosage and provide reminders at the time of dose, which can be recorded for understanding the patient’s daily routine.
The global smart inhalers market is analyzed under three different scenarios, namely, moderate growth, rapid growth, and diminishing growth. Market growth is attributed to the rapid increase in the incidence of respiratory diseases, rise in air pollution, and growth in healthcare burden, owing to higher cases of asthma and COPD. In addition, expected increase in adherence to smart inhalers is another major factor that drives the growth of the smart inhalers market. However, limited availability of smart inhalers, high cost of asthma and COPD treatment, and resistance toward adoption of smart inhalers are expected to hinder the market growth.
The market is segmented on the basis of product, indication, end user, and geography. By product, it is segmented into inhalers and nebulizers. Inhalers dominates the market, which is further divided into dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Based on indication, smart inhalers are bifurcated into asthma and COPD.
Based on distribution channel, it is divided into hospitals, retail pharmacies, and online pharmacies. In terms of geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the leading revenue-generating region, whereas Asia-Pacific is projected to grow at the high CAGR, owing to rise in demand for smart inhalers and increase in COPD and asthma cases.
KEY BENEFITS FOR STAKEHOLDERS
By Product
The global smart inhalers market is analyzed under three different scenarios, namely, moderate growth, rapid growth, and diminishing growth. Market growth is attributed to the rapid increase in the incidence of respiratory diseases, rise in air pollution, and growth in healthcare burden, owing to higher cases of asthma and COPD. In addition, expected increase in adherence to smart inhalers is another major factor that drives the growth of the smart inhalers market. However, limited availability of smart inhalers, high cost of asthma and COPD treatment, and resistance toward adoption of smart inhalers are expected to hinder the market growth.
The market is segmented on the basis of product, indication, end user, and geography. By product, it is segmented into inhalers and nebulizers. Inhalers dominates the market, which is further divided into dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Based on indication, smart inhalers are bifurcated into asthma and COPD.
Based on distribution channel, it is divided into hospitals, retail pharmacies, and online pharmacies. In terms of geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the leading revenue-generating region, whereas Asia-Pacific is projected to grow at the high CAGR, owing to rise in demand for smart inhalers and increase in COPD and asthma cases.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global smart inhalers market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A quantitative analysis from 2019 to 2026 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
- In-depth analysis of the market based on products such as inhalers and nebulizers is carried out in the report.
- The global smart inhalers market scenario is comprehensively analyzed in accordance to the key cities.
By Product
- Inhalers
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Hospitals
- Ambulatory Surgical Centers
- Others
- Hospitals
- Retail Pharmacies
- Online Pharmacies
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- AstraZeneca, plc.
- GlaxoSmithKline, plc
- Novartis International AG
- Adherium Limited
- Boehringer Ingelheim Group
- Cohero Health Group
- Vectura Group, plc.
- Opko Health Group
- Teva Pharmaceutical Industries Ltd.
- ResMed Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Research methodology
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings
2.1.1. Top investment pockets
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key forces shaping smart Inhalers market
3.2.1. Moderate bargaining power of suppliers
3.2.2. High bargaining power of buyers
3.2.3. High threat of new entrants
3.2.4. Moderate threat of substitutes
3.2.5. High intensity of rivalry
3.3. Value Chain Analysis
3.5. Industry pain point analysis
3.6. Patent Analysis
3.7. Market share analysis
3.8. Market Dynamics
3.8.1. Drivers
3.8.1.1. Increase in Air Pollution
3.8.1.2. Increase In Population Susceptible To Indoor Air Pollutants
3.8.1.3. Increasing Prevalence Of COPD and Asthma ly
3.8.2. Restraints
3.8.2.1. Misusing Data And Data Privacy
3.8.2.2. Overall High Cost Of Asthma And COPD Treatment
3.8.3. Opportunities
3.8.3.1. Increased Focus Towards Advanced Treatment Protocols
CHAPTER 4: SMART INHALERS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Inhalers
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.3.1. Dry Powder Inhalers
4.2.3.2. Metered Dose Inhalers
4.3. Nebulizers
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
CHAPTER 5: SMART INHALERS MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Asthma
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. COPD
5.3.1. Market size and Forecast
5.3.2. Market analysis, by country
CHAPTER 6: SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital pharmacies
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Retail Pharmacies
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Online Pharmacies
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: SMART INHALERS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America market size and forecast, by product type
7.2.3. North America market size and forecast, by indication
7.2.4. North America market size and forecast, by distribution channel
7.2.6. North America market size and forecast, by country
7.2.6.1. U.S. market size and forecast, by product type
7.2.6.2. U.S. market size and forecast, by indication
7.2.6.3. U.S. market size and forecast, by distribution channel
7.2.6.5. Canada market size and forecast, by product type
7.2.6.6. Canada market size and forecast, by indication
7.2.6.7. Canada market size and forecast, by distribution channel
7.2.6.8. Mexico market size and forecast, by product type
7.2.6.9. Mexico market size and forecast, by indication
7.2.6.10. Mexico market size and forecast, by distribution channel
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe market size and forecast, by product type
7.3.3. Europe market size and forecast, by indication
7.3.4. Europe market size and forecast, by distribution channel
7.3.5. Europe market size and forecast, by country
7.3.5.1. Germany market size and forecast, by product type
7.3.5.2. Germany market size and forecast, by indication
7.3.5.3. Germany market size and forecast, by distribution channel
7.3.5.4. France market size and forecast, by product type
7.3.5.5. France market size and forecast, by indication
7.3.5.6. France market size and forecast, by distribution channel
7.3.5.8. UK market size and forecast, by product type
7.3.5.9. UK market size and forecast, by indication
7.3.5.10. UK market size and forecast, by distribution channel
7.3.5.11. Italy market size and forecast, by product type
7.3.5.12. Italy market size and forecast, by indication
7.3.5.13. Italy market size and forecast, by distribution channel
7.3.5.14. Spain market size and forecast, by product type
7.3.5.15. Spain market size and forecast, by indication
7.3.5.16. Spain market size and forecast, by distribution channel
7.3.5.17. Rest of Europe market size and forecast, by product type
7.3.5.18. Rest of Europe market size and forecast, by indication
7.3.5.19. Rest of Europe market size and forecast, by distribution channel
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by product type
7.4.3. Asia-Pacific market size and forecast, by indication
7.4.4. Asia-Pacific market size and forecast, by distribution channel
7.4.5. Asia-Pacific market size and forecast, by country
7.4.5.1. Japan market size and forecast, by product type
7.4.5.2. Japan market size and forecast, by indication
7.4.5.3. Japan market size and forecast, by distribution channel
7.4.5.4. China market size and forecast, by product type
7.4.5.5. China market size and forecast, by indication
7.4.5.6. China market size and forecast, by distribution channel
7.4.5.7. India market size and forecast, by product type
7.4.5.8. India market size and forecast, by indication
7.4.5.9. India market size and forecast, by distribution channel
7.4.5.10. Australia market size and forecast, by product type
7.4.5.11. Australia market size and forecast, by indication
7.4.5.12. Australia market size and forecast, by distribution channel
7.4.5.13. Rest of Asia-Pacific market size and forecast, by product type
7.4.5.14. Rest of Asia-Pacific market size and forecast, by indication
7.4.5.15. Rest of Asia-Pacific market size and forecast, by distribution channel
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by product type
7.5.3. LAMEA market size and forecast, by indication
7.5.4. LAMEA market size and forecast, by distribution channel
7.5.5. LAMEA market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by product type
7.5.5.2. Brazil market size and forecast, by indication
7.5.5.3. Brazil market size and forecast, by distribution channel
7.5.5.4. South Africa market size and forecast, by product type
7.5.5.5. South Africa market size and forecast, by indication
7.5.5.6. South Africa market size and forecast, by distribution channel
7.5.5.7. Rest of LAMEA market size and forecast, by product type
7.5.5.8. Rest of LAMEA market size and forecast, by indication
7.5.5.9. Rest of LAMEA market size and forecast, by distribution channel
CHAPTER 8: COMPANY PROFILES
8.1. Adherium Limited
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. AstraZeneca PLC
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Boehringer Ingelheim group
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. Cohero Health, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.5. GlaxoSmithKline plc
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Novartis International AG
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. OPKO Health, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. ResMed Inc. (Propeller Health)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Teva Pharmaceutical Industries Limited
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Vectura Group plc
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
1.1. Report description
1.2. Research methodology
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings
2.1.1. Top investment pockets
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key forces shaping smart Inhalers market
3.2.1. Moderate bargaining power of suppliers
3.2.2. High bargaining power of buyers
3.2.3. High threat of new entrants
3.2.4. Moderate threat of substitutes
3.2.5. High intensity of rivalry
3.3. Value Chain Analysis
3.5. Industry pain point analysis
3.6. Patent Analysis
3.7. Market share analysis
3.8. Market Dynamics
3.8.1. Drivers
3.8.1.1. Increase in Air Pollution
3.8.1.2. Increase In Population Susceptible To Indoor Air Pollutants
3.8.1.3. Increasing Prevalence Of COPD and Asthma ly
3.8.2. Restraints
3.8.2.1. Misusing Data And Data Privacy
3.8.2.2. Overall High Cost Of Asthma And COPD Treatment
3.8.3. Opportunities
3.8.3.1. Increased Focus Towards Advanced Treatment Protocols
CHAPTER 4: SMART INHALERS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Inhalers
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.3.1. Dry Powder Inhalers
4.2.3.2. Metered Dose Inhalers
4.3. Nebulizers
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
CHAPTER 5: SMART INHALERS MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Asthma
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. COPD
5.3.1. Market size and Forecast
5.3.2. Market analysis, by country
CHAPTER 6: SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital pharmacies
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Retail Pharmacies
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Online Pharmacies
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: SMART INHALERS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America market size and forecast, by product type
7.2.3. North America market size and forecast, by indication
7.2.4. North America market size and forecast, by distribution channel
7.2.6. North America market size and forecast, by country
7.2.6.1. U.S. market size and forecast, by product type
7.2.6.2. U.S. market size and forecast, by indication
7.2.6.3. U.S. market size and forecast, by distribution channel
7.2.6.5. Canada market size and forecast, by product type
7.2.6.6. Canada market size and forecast, by indication
7.2.6.7. Canada market size and forecast, by distribution channel
7.2.6.8. Mexico market size and forecast, by product type
7.2.6.9. Mexico market size and forecast, by indication
7.2.6.10. Mexico market size and forecast, by distribution channel
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe market size and forecast, by product type
7.3.3. Europe market size and forecast, by indication
7.3.4. Europe market size and forecast, by distribution channel
7.3.5. Europe market size and forecast, by country
7.3.5.1. Germany market size and forecast, by product type
7.3.5.2. Germany market size and forecast, by indication
7.3.5.3. Germany market size and forecast, by distribution channel
7.3.5.4. France market size and forecast, by product type
7.3.5.5. France market size and forecast, by indication
7.3.5.6. France market size and forecast, by distribution channel
7.3.5.8. UK market size and forecast, by product type
7.3.5.9. UK market size and forecast, by indication
7.3.5.10. UK market size and forecast, by distribution channel
7.3.5.11. Italy market size and forecast, by product type
7.3.5.12. Italy market size and forecast, by indication
7.3.5.13. Italy market size and forecast, by distribution channel
7.3.5.14. Spain market size and forecast, by product type
7.3.5.15. Spain market size and forecast, by indication
7.3.5.16. Spain market size and forecast, by distribution channel
7.3.5.17. Rest of Europe market size and forecast, by product type
7.3.5.18. Rest of Europe market size and forecast, by indication
7.3.5.19. Rest of Europe market size and forecast, by distribution channel
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by product type
7.4.3. Asia-Pacific market size and forecast, by indication
7.4.4. Asia-Pacific market size and forecast, by distribution channel
7.4.5. Asia-Pacific market size and forecast, by country
7.4.5.1. Japan market size and forecast, by product type
7.4.5.2. Japan market size and forecast, by indication
7.4.5.3. Japan market size and forecast, by distribution channel
7.4.5.4. China market size and forecast, by product type
7.4.5.5. China market size and forecast, by indication
7.4.5.6. China market size and forecast, by distribution channel
7.4.5.7. India market size and forecast, by product type
7.4.5.8. India market size and forecast, by indication
7.4.5.9. India market size and forecast, by distribution channel
7.4.5.10. Australia market size and forecast, by product type
7.4.5.11. Australia market size and forecast, by indication
7.4.5.12. Australia market size and forecast, by distribution channel
7.4.5.13. Rest of Asia-Pacific market size and forecast, by product type
7.4.5.14. Rest of Asia-Pacific market size and forecast, by indication
7.4.5.15. Rest of Asia-Pacific market size and forecast, by distribution channel
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by product type
7.5.3. LAMEA market size and forecast, by indication
7.5.4. LAMEA market size and forecast, by distribution channel
7.5.5. LAMEA market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by product type
7.5.5.2. Brazil market size and forecast, by indication
7.5.5.3. Brazil market size and forecast, by distribution channel
7.5.5.4. South Africa market size and forecast, by product type
7.5.5.5. South Africa market size and forecast, by indication
7.5.5.6. South Africa market size and forecast, by distribution channel
7.5.5.7. Rest of LAMEA market size and forecast, by product type
7.5.5.8. Rest of LAMEA market size and forecast, by indication
7.5.5.9. Rest of LAMEA market size and forecast, by distribution channel
CHAPTER 8: COMPANY PROFILES
8.1. Adherium Limited
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. AstraZeneca PLC
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Boehringer Ingelheim group
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. Cohero Health, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.5. GlaxoSmithKline plc
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Novartis International AG
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. OPKO Health, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. ResMed Inc. (Propeller Health)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Teva Pharmaceutical Industries Limited
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Vectura Group plc
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. SMART INHALERS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. SMART INHALERS MARKET FOR INHALERS, BY REGION, 2018–2026 ($MILLION)
TABLE 03. SMART INHALERS MARKET FOR NEBULIZERS, BY REGION, 2018–2026 ($MILLION)
TABLE 04. SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 05. SMART INHALERS MARKET FOR , BY REGION, 2018–2026, ($MILLION)
TABLE 06. SMART INHALERS MARKET FOR COPD, BY REGION, 2018–2026, ($MILLION)
TABLE 07. SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 08. SMART INHALERS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2018–2026, ($MILLION)
TABLE 09. SMART INHALERS MARKET RETAIL PHARMACIES, BY REGION, 2018–2026, ($MILLION)
TABLE 10. SMART INHALERS MARKET ONLINE PHARMACIES, BY REGION, 2018–2026, ($MILLION)
TABLE 11. SMART INHALERS MARKET, BY REGION, 2018–2026, ($MILLION)
TABLE 12. NORTH AMERICA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 13. NORTH AMERICA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 14. NORTH AMERICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 15. NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY 2018–2026, ($MILLION)
TABLE 16. U.S. SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 17. U.S. SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 18. U.S. SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 19. CANADA SMART INHALERS MARKET, BY PRODUCT TYPE2018–2026, ($MILLION)
TABLE 20. CANADA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 21. CANADA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 22. MEXICO SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 23. MEXICO SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 24. MEXICO SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 25. EUROPE SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 26. EUROPE SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 27. EUROPE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 28. EUROPE SMART INHALERS MARKET, BY COUNTRY, 2018–2026, ($MILLION)
TABLE 29. GERMANY SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 30. GERMANY SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 31. GERMANY SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 32. FRANCE SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 33. FRANCE SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 34. FRANCE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 35. UK SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 36. UK SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 37. UK SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 38. ITALY SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 39. ITALY SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 40. ITALY SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 41. SPAIN SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 42. SPAIN SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 43. SPAIN SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 44. REST OF EUROPE SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 45. REST OF EUROPE SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 46. REST OF EUROPE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 47. ASIA-PACIFIC SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 48. ASIA-PACIFIC SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 49. ASIA-PACIFIC SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 50. ASIA-PACIFIC SMART INHALERS MARKET, BY COUNTRY, 2018–2026, ($MILLION)
TABLE 51. JAPAN SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 52. JAPAN SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 53. JAPAN SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 54. CHINA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 55. CHINA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 56. CHINA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 57. INDIA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 58. INDIA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 59. INDIA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 60. AUSTRALIA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 61. AUSTRALIA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 62. AUSTRALIA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 63. REST OF ASIA-PACIFIC SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 64. REST OF ASIA-PACIFIC SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 66. LAMEA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 67. LAMEA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 68. LAMEA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 69. LAMEA SMART INHALERS MARKET, BY COUNTRY, 2018–2026, ($MILLION)
TABLE 70. BRAZIL SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 71. BRAZIL SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 72. BRAZIL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 73. SOUTH AFRICA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 74. SOUTH AFRICA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 75. SOUTH AFRICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 76. REST OF LAMEA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 77. REST OF LAMEA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 78. REST OF LAMEA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 79. ADHERIUM: COMPANY SNAPSHOT
TABLE 80. ADHERIUM: OPERATING SEGMENTS
TABLE 81. ADHERIUM: PRODUCT PORTFOLIO
TABLE 82. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 83. ASTRAZENECA: OPERATING SEGMENTS
TABLE 84. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 85. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 86. BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 87. COHERO HEALTH: COMPANY SNAPSHOT
TABLE 88. COHERO HEALTH: PRODUCT PORTFOLIO
TABLE 89. GSK: COMPANY SNAPSHOT
TABLE 90. GSK: OPERATING SEGMENTS
TABLE 91. NOVARTIS: COMPANY SNAPSHOT
TABLE 92. NOVARTIS: OPERATING SEGMENTS
TABLE 93. NOVARTIS: PRODUCT PORTFOLIO
TABLE 94. OPKO HEALTH: COMPANY SNAPSHOT
TABLE 95. OPKO HEALTH: OPERATING SEGMENTS
TABLE 96. OPKO HEALTH: PRODUCT PORTFOLIO
TABLE 97. RESMED: COMPANY SNAPSHOT
TABLE 98. RESMED: OPERATING SEGMENTS
TABLE 99. RESMED: PRODUCT PORTFOLIO
TABLE 100. TEVA: COMPANY SNAPSHOT
TABLE 101. TEVA: OPERATING SEGMENTS
TABLE 102. TEVA: PRODUCT PORTFOLIO
TABLE 103. VECTURA: COMPANY SNAPSHOT
TABLE 104. VECTURA: OPERATING SEGMENTS
TABLE 105. VECTURA: PRODUCT PORTFOLIO
TABLE 01. SMART INHALERS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. SMART INHALERS MARKET FOR INHALERS, BY REGION, 2018–2026 ($MILLION)
TABLE 03. SMART INHALERS MARKET FOR NEBULIZERS, BY REGION, 2018–2026 ($MILLION)
TABLE 04. SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 05. SMART INHALERS MARKET FOR , BY REGION, 2018–2026, ($MILLION)
TABLE 06. SMART INHALERS MARKET FOR COPD, BY REGION, 2018–2026, ($MILLION)
TABLE 07. SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 08. SMART INHALERS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2018–2026, ($MILLION)
TABLE 09. SMART INHALERS MARKET RETAIL PHARMACIES, BY REGION, 2018–2026, ($MILLION)
TABLE 10. SMART INHALERS MARKET ONLINE PHARMACIES, BY REGION, 2018–2026, ($MILLION)
TABLE 11. SMART INHALERS MARKET, BY REGION, 2018–2026, ($MILLION)
TABLE 12. NORTH AMERICA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 13. NORTH AMERICA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 14. NORTH AMERICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 15. NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY 2018–2026, ($MILLION)
TABLE 16. U.S. SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 17. U.S. SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 18. U.S. SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 19. CANADA SMART INHALERS MARKET, BY PRODUCT TYPE2018–2026, ($MILLION)
TABLE 20. CANADA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 21. CANADA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 22. MEXICO SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 23. MEXICO SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 24. MEXICO SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 25. EUROPE SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 26. EUROPE SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 27. EUROPE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 28. EUROPE SMART INHALERS MARKET, BY COUNTRY, 2018–2026, ($MILLION)
TABLE 29. GERMANY SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 30. GERMANY SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 31. GERMANY SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 32. FRANCE SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 33. FRANCE SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 34. FRANCE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 35. UK SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 36. UK SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 37. UK SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 38. ITALY SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 39. ITALY SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 40. ITALY SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 41. SPAIN SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 42. SPAIN SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 43. SPAIN SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 44. REST OF EUROPE SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 45. REST OF EUROPE SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 46. REST OF EUROPE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 47. ASIA-PACIFIC SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 48. ASIA-PACIFIC SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 49. ASIA-PACIFIC SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 50. ASIA-PACIFIC SMART INHALERS MARKET, BY COUNTRY, 2018–2026, ($MILLION)
TABLE 51. JAPAN SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 52. JAPAN SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 53. JAPAN SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 54. CHINA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 55. CHINA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 56. CHINA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 57. INDIA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 58. INDIA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 59. INDIA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 60. AUSTRALIA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 61. AUSTRALIA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 62. AUSTRALIA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 63. REST OF ASIA-PACIFIC SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 64. REST OF ASIA-PACIFIC SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 66. LAMEA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 67. LAMEA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 68. LAMEA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 69. LAMEA SMART INHALERS MARKET, BY COUNTRY, 2018–2026, ($MILLION)
TABLE 70. BRAZIL SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 71. BRAZIL SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 72. BRAZIL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 73. SOUTH AFRICA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 74. SOUTH AFRICA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 75. SOUTH AFRICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 76. REST OF LAMEA SMART INHALERS MARKET, BY PRODUCT TYPE, 2018–2026, ($MILLION)
TABLE 77. REST OF LAMEA SMART INHALERS MARKET, BY INDICATION, 2018–2026, ($MILLION)
TABLE 78. REST OF LAMEA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026, ($MILLION)
TABLE 79. ADHERIUM: COMPANY SNAPSHOT
TABLE 80. ADHERIUM: OPERATING SEGMENTS
TABLE 81. ADHERIUM: PRODUCT PORTFOLIO
TABLE 82. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 83. ASTRAZENECA: OPERATING SEGMENTS
TABLE 84. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 85. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 86. BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 87. COHERO HEALTH: COMPANY SNAPSHOT
TABLE 88. COHERO HEALTH: PRODUCT PORTFOLIO
TABLE 89. GSK: COMPANY SNAPSHOT
TABLE 90. GSK: OPERATING SEGMENTS
TABLE 91. NOVARTIS: COMPANY SNAPSHOT
TABLE 92. NOVARTIS: OPERATING SEGMENTS
TABLE 93. NOVARTIS: PRODUCT PORTFOLIO
TABLE 94. OPKO HEALTH: COMPANY SNAPSHOT
TABLE 95. OPKO HEALTH: OPERATING SEGMENTS
TABLE 96. OPKO HEALTH: PRODUCT PORTFOLIO
TABLE 97. RESMED: COMPANY SNAPSHOT
TABLE 98. RESMED: OPERATING SEGMENTS
TABLE 99. RESMED: PRODUCT PORTFOLIO
TABLE 100. TEVA: COMPANY SNAPSHOT
TABLE 101. TEVA: OPERATING SEGMENTS
TABLE 102. TEVA: PRODUCT PORTFOLIO
TABLE 103. VECTURA: COMPANY SNAPSHOT
TABLE 104. VECTURA: OPERATING SEGMENTS
TABLE 105. VECTURA: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. TOP INVESTMENT POCKETS, 2019
FIGURE 02. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03. MODERATE BARGAINING POWER OF BUYERS
FIGURE 04. LOW THREAT OF NEW ENTRANTS
FIGURE 05. MODERATE THREAT OF SUBSTITUTES
FIGURE 06. MODERATE INTENSITY OF RIVALRY
FIGURE 07. VALUE CHAIN ANALYSIS
FIGURE 08. INDUSTRY PAIN POINT ANALYSIS
FIGURE 09. SMART INHALERS DEVICES AND CONSUMABLES: MARKET SHARE ANALYSIS, 2018
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR DEVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR CONSUMABLES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR COPD, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. ADHERIUM: NET SALES, 2016–2018 ($MILLION)
FIGURE 18. ADHERIUM: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 19. ASTRAZENECA: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. ASTRAZENECA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 21. ASTRAZENECA: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 22. BOEHRINGER INGELHEIM: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. BOEHRINGER INGELHEIM: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. BOEHRINGER INGELHEIM: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 25. GSK: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. GSK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. GSK: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 28. NOVARTIS: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. NOVARTIS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 31. OPKO HEALTH: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. OPKO HEALTH: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. OPKO HEALTH: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 34. RESMED: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. RESMED: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 36. TEVA: NET SALES, 2016–2018 ($MILLION)
FIGURE 37. TEVA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 38. VECTURA: NET SALES, 2016–2018 ($MILLION)
FIGURE 39. VECTURA: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 01. TOP INVESTMENT POCKETS, 2019
FIGURE 02. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03. MODERATE BARGAINING POWER OF BUYERS
FIGURE 04. LOW THREAT OF NEW ENTRANTS
FIGURE 05. MODERATE THREAT OF SUBSTITUTES
FIGURE 06. MODERATE INTENSITY OF RIVALRY
FIGURE 07. VALUE CHAIN ANALYSIS
FIGURE 08. INDUSTRY PAIN POINT ANALYSIS
FIGURE 09. SMART INHALERS DEVICES AND CONSUMABLES: MARKET SHARE ANALYSIS, 2018
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR DEVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR CONSUMABLES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR COPD, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SMART INHALERS MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. ADHERIUM: NET SALES, 2016–2018 ($MILLION)
FIGURE 18. ADHERIUM: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 19. ASTRAZENECA: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. ASTRAZENECA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 21. ASTRAZENECA: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 22. BOEHRINGER INGELHEIM: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. BOEHRINGER INGELHEIM: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. BOEHRINGER INGELHEIM: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 25. GSK: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. GSK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. GSK: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 28. NOVARTIS: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. NOVARTIS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 31. OPKO HEALTH: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. OPKO HEALTH: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. OPKO HEALTH: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 34. RESMED: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. RESMED: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 36. TEVA: NET SALES, 2016–2018 ($MILLION)
FIGURE 37. TEVA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 38. VECTURA: NET SALES, 2016–2018 ($MILLION)
FIGURE 39. VECTURA: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
